kt 5823 has been researched along with taurochenodeoxycholic acid in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (taurochenodeoxycholic acid) | Trials (taurochenodeoxycholic acid) | Recent Studies (post-2010) (taurochenodeoxycholic acid) |
---|---|---|---|---|---|
317 | 0 | 59 | 873 | 27 | 423 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, F; Ji, L; Liang, X; Shi, Z; Su, F; Tie, R; Xing, W; Yu, J; Yu, L; Zhang, H; Zhu, M | 1 |
1 other study(ies) available for kt 5823 and taurochenodeoxycholic acid
Article | Year |
---|---|
Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.
Topics: Animals; Apoptosis; Atrial Natriuretic Factor; Carbazoles; Caspase 3; Cell Hypoxia; Cell Line; Creatine Kinase; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Stress; Heart Ventricles; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Transcription Factor CHOP; Ventricular Function | 2015 |